Although EZH2 protein levels were reduced after HAT1 silencing, treatment with the proteasome inhibitor MG132 restored EZH2 protein levels in HAT1-knockdown pancreatic cancer cells (Fig. 3e). Here, HAT1 is linked to familial pancreatic carcinoma.